EMAS Conference Highlights
OBGYN.net Conference CoverageFrom the European Menopause and Andropause Society (EMAS) 5th Congress, Copenhagen, Denmark-July, 2000
Audio Link in English | Audio Link in German *requires RealPlayer- free download
OBGYN.net: “Please tell us what some of the highlights of this Conference are.”
Dr. Martin Birkhauser: “We had discussions about breast cancer with HRT which is a very important subject and then long term substitution and safety - when to give long term substitution and when not, and the low dose regiments one aspect was including new molecules such as tibolone.”
OBGYN.net: “Can you tell us something about the results regarding estrogens and breast cancer?”
Dr. Martin Birkhauser: “The discussion is not yet closed, we’re in the middle of discussions but there has been a confirmation that the risks show a slight increase with HRT but only for the diagnosis not for mortality and that eventually progestins might increase the risk but these discussions are not closed.”
OBGYN.net: “Can you tell us when and where the next Conference will be?”
Dr. Martin Birkhauser: “The next Congress will be in three years in the year 2003, and it will be in Israel in Jerusalem.”
OBGYN.net: “That’s a long time, a lot can happen in three years. Will there be other Conferences in between about this theme?”
Dr. Martin Birkhauser: “Yes, of course. We’ll have the next Amsterdam meeting next year and then we will organize local meetings that are designed to be concentrated on education. In fact, I think that is an important task especially in comparison to having been less lucky as the west European countries.”
OBGYN.net: “Are there many European participants in this Conference?”
Dr. Martin Birkhauser: “We had more than 4,200 participants and most of them were from Europe but overall we had 72 countries represented.”
OBGYN.net: “Thank you.”
